89Zr-S095012

N/A

Report date: 2025/09/24 14:01:31
NME

Base Information

Drug Name89Zr-S095012
Drug Alias Name89Zr-S-095012
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsProgrammed death-ligand 1Tumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut De Recherches Internationales Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdir SarlInstitut De Recherches Internationales Servier
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A